Haemonetics CFO William P. Burke to Retire

Haemonetics Corporation announced that William P. Burke, executive VP, chief financial officer (CFO), has decided to retire from the company. Burke will continue to serve as CFO while the Company conducts a search for his successor, and he will work closely with Haemonetics’ next CFO through June 30, 2022 to ensure a seamless transition.
 
Burke joined Haemonetics as CFO in August 2016 after spending more than 20 years in finance and business leadership roles at leading healthcare companies, including Medtronic plc, Covidien plc, and Tyco Healthcare.
 
“Bill was my first hire at Haemonetics and has been the co-architect of our turnaround,” said Chris Simon, Haemonetics’ CEO. “He has directed strategic financial initiatives enabling us to best leverage our resources for investments in the people, products, and processes that are fueling our long-term growth. I am grateful Bill will lend his experience and expertise to the selection of our next CFO, and a successful transition. I offer my sincere appreciation to Bill for his many contributions to our company.”
 
According to Burke, “I am very proud to have worked with the dedicated management team at Haemonetics and, in particular, the company’s world-class finance organization that will continue to successfully support the ongoing initiatives of Haemonetics. I have confidence in the strategy and the future success of the company.”